Refractory anti-viral resistant CMV retinitis in an immunological nonresponder person living with HIV

Cytomegalovirus (CMV) retinitis caused by drug-resistant viruses poses a major challenge in immunocompromised patients. We present the case of a patient living with HIV with persistently low CD4+ T cells count despite effective antiretroviral therapy, who experienced multiple episodes of CMV retinitis associated with iterative acquisition of resistance. The failure of ganciclovir and foscarnet treatments led us to implement a combined therapy of intravenous cidofovir, high-dose ganciclovir, and anti-CMV immunoglobulin as well as intravitreal injections of ganciclovir. This triple therapy was successful but resulted in significant myelotoxicity. Furthermore, the relapse of CMV retinitis and/or CMV viremia with each therapeutic de-escalation reflects the high level of immunodeficiency in our patient, despite sustained control of HIV viremia for several months. This case report highlights the need for a particular management of CMV infection in patients living with HIV who are immunological nonresponders.

Authors

Institutions

Publication Details

Journal
International Journal of Infectious Diseases
Published
2024-09-01
DOI
https://doi.org/10.1016/j.ijid.2024.107229
Citations
2
Primary Topic
Cytomegalovirus and herpesvirus research
Type
article
Field-Weighted Citation Impact
0.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Refractory anti-viral resistant CMV retinitis in an immunological nonresponder person living with HIV

David Boutolleau, Nadhira Fidouh, Alexandra Serris, Mayda Rahi et al.
2 citations
International Journal of Infectious Diseases
Cytomegalovirus and herpesvirus research
0.77
article

Refractory anti-viral resistant CMV retinitis in an immunological nonresponder person living with HIV

David Boutolleau, Nadhira Fidouh, Alexandra Serris, Mayda Rahi, C. Rioux, Véronique Joly
article en
2 citations

Abstract

Cytomegalovirus (CMV) retinitis caused by drug-resistant viruses poses a major challenge in immunocompromised patients. We present the case of a patient living with HIV with persistently low CD4+ T cells count despite effective antiretroviral therapy, who experienced multiple episodes of CMV retinitis associated with iterative acquisition of resistance. The failure of ganciclovir and foscarnet treatments led us to implement a combined therapy of intravenous cidofovir, high-dose ganciclovir, and anti-CMV immunoglobulin as well as intravitreal injections of ganciclovir. This triple therapy was successful but resulted in significant myelotoxicity. Furthermore, the relapse of CMV retinitis and/or CMV viremia with each therapeutic de-escalation reflects the high level of immunodeficiency in our patient, despite sustained control of HIV viremia for several months. This case report highlights the need for a particular management of CMV infection in patients living with HIV who are immunological nonresponders.

International Journal of Infectious DiseasesVol. 148
Inserm (FR), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Pitié-Salpêtrière Hospital (FR), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Hôpital Bichat-Claude-Bernard (FR)
Good health and well-being
Openalex Percentile: Top 26%
Cytomegalovirus and herpesvirus research
0.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.